(CNN) -- The FDA has revised the emergency use authorization for Evusheld, a monoclonal antibody against COVID-19 for immunocompromised people and those who cannot be vaccinated for medical reasons, to double the initial dose. People who've already received the drug should go back for an additional dose as soon as possible, the agency said.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
